Page last updated: 2024-08-18

pyridostigmine bromide and Lymphoma, B-Cell

pyridostigmine bromide has been researched along with Lymphoma, B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Habermann, TM; O'Neill, BP; Salomao, DR; Vernino, S1

Other Studies

1 other study(ies) available for pyridostigmine bromide and Lymphoma, B-Cell

ArticleYear
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil.
    Neurology, 2005, Aug-23, Volume: 65, Issue:4

    Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Brain Neoplasms; Cell Transformation, Neoplastic; Drug Therapy, Combination; Female; Frontal Lobe; Humans; Immunity, Cellular; Immunosuppressive Agents; Lymphoma, B-Cell; Magnetic Resonance Imaging; Myasthenia Gravis; Mycophenolic Acid; Parietal Lobe; Prednisone; Pyridostigmine Bromide; Rituximab; T-Lymphocytes; Treatment Outcome

2005